UA57042C2 - Средство для воздействия на организм - Google Patents
Средство для воздействия на организм Download PDFInfo
- Publication number
- UA57042C2 UA57042C2 UA99042270A UA99042270A UA57042C2 UA 57042 C2 UA57042 C2 UA 57042C2 UA 99042270 A UA99042270 A UA 99042270A UA 99042270 A UA99042270 A UA 99042270A UA 57042 C2 UA57042 C2 UA 57042C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- potentiated
- homeopathic
- potentialised
- morphine
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 16
- 230000001632 homeopathic effect Effects 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 10
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims abstract description 9
- 208000007848 Alcoholism Diseases 0.000 claims abstract description 7
- 201000007930 alcohol dependence Diseases 0.000 claims abstract description 7
- 229960005195 morphine hydrochloride Drugs 0.000 claims abstract description 5
- XCKKIKBIPZJUET-VYKNHSEDSA-N morphine hydrochloride Chemical compound Cl.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O XCKKIKBIPZJUET-VYKNHSEDSA-N 0.000 claims abstract description 5
- 230000002588 toxic effect Effects 0.000 claims abstract description 5
- 231100000563 toxic property Toxicity 0.000 claims abstract description 5
- 239000008896 Opium Substances 0.000 claims abstract description 4
- 229930013930 alkaloid Natural products 0.000 claims abstract description 4
- 150000003797 alkaloid derivatives Chemical class 0.000 claims abstract description 4
- 229960005181 morphine Drugs 0.000 claims abstract description 4
- 229960001027 opium Drugs 0.000 claims abstract description 4
- 239000012895 dilution Substances 0.000 claims description 8
- 238000010790 dilution Methods 0.000 claims description 8
- 230000004071 biological effect Effects 0.000 claims description 3
- 238000012876 topography Methods 0.000 claims 1
- 231100000614 poison Toxicity 0.000 abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 239000002574 poison Substances 0.000 abstract description 6
- 230000007096 poisonous effect Effects 0.000 abstract description 6
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract description 2
- 229960002715 nicotine Drugs 0.000 abstract description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000004081 narcotic agent Substances 0.000 abstract 1
- 241000208125 Nicotiana Species 0.000 description 8
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 5
- 230000000391 smoking effect Effects 0.000 description 5
- 231100000167 toxic agent Toxicity 0.000 description 5
- 239000000729 antidote Substances 0.000 description 4
- 206010013663 drug dependence Diseases 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 231100000566 intoxication Toxicity 0.000 description 4
- 230000035987 intoxication Effects 0.000 description 4
- 208000011117 substance-related disease Diseases 0.000 description 4
- 206010012335 Dependence Diseases 0.000 description 3
- 208000005374 Poisoning Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229940075522 antidotes Drugs 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229940041669 mercury Drugs 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- VRGUHZVPXCABAX-UHFFFAOYSA-N methyllead Chemical compound [Pb]C VRGUHZVPXCABAX-UHFFFAOYSA-N 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Addiction (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Изобретение относится к медицине, в частности к средству для воздействия на организм на основе естественного или искусственного продукта с токсическими свойствами. Исходный продукт с токсическими свойствами (это могут быть наркотические вещества, алкоголь, никотин, промышленные токсические вещества, военные токсины) потенцируют путем многократного разведения и встряхивания по гомеопатическому методу и используют совместно с исходным продуктом в гомеопатической лекарственной форме. Так, в случае лечения алкоголизма по этому методу в качестве исходного продукта для потенцирования используют этанол. В случае лечения наркотической зависимости для потенцирования применяют наркотические вещества (опиаты, морфин, гидрохлорид морфина). Потенциализированный агент в соответствии с настоящим изобретением может применяться в любой гомеопатической лекарственной форме, желательно вместе с исходным продуктом.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU96118931A RU2132181C1 (ru) | 1996-09-30 | 1996-09-30 | Средство для воздействия на организм |
| PCT/RU1997/000305 WO1998014162A1 (fr) | 1996-09-30 | 1997-09-29 | Agent permettant d'agir sur l'organisme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA57042C2 true UA57042C2 (ru) | 2003-06-16 |
Family
ID=20185731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA99042270A UA57042C2 (ru) | 1996-09-30 | 1997-09-29 | Средство для воздействия на организм |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU4729397A (ru) |
| EA (1) | EA001601B1 (ru) |
| RU (1) | RU2132181C1 (ru) |
| UA (1) | UA57042C2 (ru) |
| WO (1) | WO1998014162A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| AU2003208170B2 (en) | 2002-02-28 | 2006-11-23 | Birseck Pty Ltd | Treatment of effect of chemicals with their ultradilute stereoisomers |
| UA76639C2 (ru) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатическое лекарственное средство и способ лечения эректильных дисфункций |
| RU2309732C1 (ru) | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| EA030542B1 (ru) | 2010-07-15 | 2018-08-31 | Олег Ильич ЭПШТЕЙН | Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии |
| RU2541167C2 (ru) * | 2013-03-29 | 2015-02-10 | Александр Николаевич Куршев | Способ лечения аддикции |
| WO2015130191A1 (ru) * | 2014-02-25 | 2015-09-03 | Анатолий Викторович ЗАЗУЛЯ | Устройство специфических антидотов аллопатическими лекарственными средствами в общей внешней (вторичной) упаковке |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2074700C1 (ru) * | 1993-03-10 | 1997-03-10 | Наталья Борисовна Зубова | Способ получения биологически активного препарата |
| RU2043768C1 (ru) * | 1994-05-24 | 1995-09-20 | Алексей Владимирович Попов | Способ лечения алкоголизма |
| RU2030910C1 (ru) * | 1994-08-11 | 1995-03-20 | Григорий Семенович Черныш | Средство для воздействия на организм |
| RU2084217C1 (ru) * | 1996-02-12 | 1997-07-20 | Эпштейн Олег Ильич | Лекарственное средство |
-
1996
- 1996-09-30 RU RU96118931A patent/RU2132181C1/ru active IP Right Revival
-
1997
- 1997-09-29 UA UA99042270A patent/UA57042C2/ru unknown
- 1997-09-29 WO PCT/RU1997/000305 patent/WO1998014162A1/ru active Application Filing
- 1997-09-29 EA EA199900298A patent/EA001601B1/ru not_active IP Right Cessation
- 1997-09-29 AU AU47293/97A patent/AU4729397A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2132181C1 (ru) | 1999-06-27 |
| EA199900298A1 (ru) | 1999-08-26 |
| WO1998014162A1 (fr) | 1998-04-09 |
| EA001601B1 (ru) | 2001-06-25 |
| AU4729397A (en) | 1998-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8003696B2 (en) | Composition and method for treating bacterial, viral, fungal diseases, inflammation and pain | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| UA57042C2 (ru) | Средство для воздействия на организм | |
| RU2007133435A (ru) | Способ комбинированного лечения и применимые для этого сочетания лекарственных средств | |
| NZ547946A (en) | Treatment composition | |
| RU2445971C2 (ru) | Водный экстракт листьев табака и его применение при лечении зависимости | |
| JP4445263B2 (ja) | 経皮薬物送達システム | |
| AU2008253776A8 (en) | Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence | |
| AU2006340367B2 (en) | Composition for treating bacterial, viral, fungal diseases, inflammation and pain | |
| RU2148993C1 (ru) | Способ лечения токсикомании | |
| WO1981001653A1 (en) | Sedative drug | |
| JP2005511653A6 (ja) | 神経麻痺及び神経機能障害に対する治療の為の経皮薬物 | |
| RU2115421C1 (ru) | Фармацевтическая композиция, обладающая иммуномодулирующим и гиполипидемическим действием | |
| CA2806790C (en) | Composition and method for oral delivery of cobra venom | |
| WO2015161180A1 (en) | Analgesic compositions and methods of use | |
| JPS59116219A (ja) | 中枢鎮痛剤とビタミンｂ１２又はその誘導体との組合せを活性成分として含む新規な鎮痛剤組成物 | |
| WO2001058464A1 (fr) | Forme posologique d'ivermectine a dispersion aqueuse utilisee pour soigner ectoparasitose et endoparasitose | |
| RU2426531C1 (ru) | Жидкая водная фармацевтическая композиция амброксола и фармацевтический препарат на ее основе, предназначенные для лечения заболеваний дыхательных путей с образованием вязкой мокроты (варианты) | |
| RU2147242C1 (ru) | Средство для лечения табакокурения | |
| JP2002281939A (ja) | 生薬食料製品 | |
| RU2140277C1 (ru) | Противовоспалительное средство с иммуномодулирующими свойствами | |
| RU96117561A (ru) | Способ лечения токсикомании | |
| RU2133617C1 (ru) | Седативное лекарственное средство "шалун" | |
| KR101506708B1 (ko) | 금연 보조용 설하분무제와 트로키를 제조하는 방법 및 이에 의하여 제조된 설하분무제와 트로키 | |
| CN114832087A (zh) | 还原型谷胱甘肽在制备具有溶解夏科-莱登晶体作用的制剂中的应用 |